Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 1
2007 2
2008 4
2009 1
2011 1
2012 1
2013 3
2014 1
2015 1
2017 2
2018 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Structural Basis of PML-RARA Oncoprotein Targeting by Arsenic Unravels a Cysteine Rheostat Controlling PML Body Assembly and Function.
Bercier P, Wang QQ, Zang N, Zhang J, Yang C, Maimaitiyiming Y, Abou-Ghali M, Berthier C, Wu C, Niwa-Kawakita M, Dirami T, Geoffroy MC, Ferhi O, Quentin S, Benhenda S, Ogra Y, Gueroui Z, Zhou C, Naranmandura H, de Thé H, Lallemand-Breitenbach V. Bercier P, et al. Among authors: niwa kawakita m. Cancer Discov. 2023 Dec 12;13(12):2548-2565. doi: 10.1158/2159-8290.CD-23-0453. Cancer Discov. 2023. PMID: 37655965 Free PMC article.
PML nuclear bodies, membrane-less domains acting as ROS sensors?
Niwa-Kawakita M, Wu HC, Thé H, Lallemand-Breitenbach V. Niwa-Kawakita M, et al. Semin Cell Dev Biol. 2018 Aug;80:29-34. doi: 10.1016/j.semcdb.2017.11.007. Epub 2017 Nov 20. Semin Cell Dev Biol. 2018. PMID: 29157919 Review.
Exploration of nuclear body-enhanced sumoylation reveals that PML represses 2-cell features of embryonic stem cells.
Tessier S, Ferhi O, Geoffroy MC, González-Prieto R, Canat A, Quentin S, Pla M, Niwa-Kawakita M, Bercier P, Rérolle D, Tirard M, Therizols P, Fabre E, Vertegaal ACO, de Thé H, Lallemand-Breitenbach V. Tessier S, et al. Among authors: niwa kawakita m. Nat Commun. 2022 Sep 29;13(1):5726. doi: 10.1038/s41467-022-33147-6. Nat Commun. 2022. PMID: 36175410 Free PMC article.
Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.
Schulz A, Baader SL, Niwa-Kawakita M, Jung MJ, Bauer R, Garcia C, Zoch A, Schacke S, Hagel C, Mautner VF, Hanemann CO, Dun XP, Parkinson DB, Weis J, Schröder JM, Gutmann DH, Giovannini M, Morrison H. Schulz A, et al. Among authors: niwa kawakita m. Nat Neurosci. 2013 Apr;16(4):426-33. doi: 10.1038/nn.3348. Epub 2013 Mar 3. Nat Neurosci. 2013. PMID: 23455610
PML is a ROS sensor activating p53 upon oxidative stress.
Niwa-Kawakita M, Ferhi O, Soilihi H, Le Bras M, Lallemand-Breitenbach V, de Thé H. Niwa-Kawakita M, et al. J Exp Med. 2017 Nov 6;214(11):3197-3206. doi: 10.1084/jem.20160301. Epub 2017 Sep 20. J Exp Med. 2017. PMID: 28931625 Free PMC article.
Author Correction: Exploration of nuclear body-enhanced sumoylation reveals that PML represses 2-cell features of embryonic stem cells.
Tessier S, Ferhi O, Geoffroy MC, González-Prieto R, Canat A, Quentin S, Pla M, Niwa-Kawakita M, Bercier P, Rérolle D, Tirard M, Therizols P, Fabre E, Vertegaal ACO, de Thé H, Lallemand-Breitenbach V. Tessier S, et al. Among authors: niwa kawakita m. Nat Commun. 2023 Jan 9;14(1):124. doi: 10.1038/s41467-022-35750-z. Nat Commun. 2023. PMID: 36624101 Free PMC article. No abstract available.
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.
Jessen WJ, Miller SJ, Jousma E, Wu J, Rizvi TA, Brundage ME, Eaves D, Widemann B, Kim MO, Dombi E, Sabo J, Hardiman Dudley A, Niwa-Kawakita M, Page GP, Giovannini M, Aronow BJ, Cripe TP, Ratner N. Jessen WJ, et al. Among authors: niwa kawakita m. J Clin Invest. 2013 Jan;123(1):340-7. doi: 10.1172/JCI60578. Epub 2012 Dec 10. J Clin Invest. 2013. PMID: 23221341 Free PMC article. Clinical Trial.
Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2.
Tanaka K, Eskin A, Chareyre F, Jessen WJ, Manent J, Niwa-Kawakita M, Chen R, White CH, Vitte J, Jaffer ZM, Nelson SF, Rubenstein AE, Giovannini M. Tanaka K, et al. Among authors: niwa kawakita m. Clin Cancer Res. 2013 Jul 15;19(14):3856-70. doi: 10.1158/1078-0432.CCR-12-3167. Epub 2013 May 28. Clin Cancer Res. 2013. PMID: 23714726 Free PMC article.
Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice.
Meinzer U, Esmiol-Welterlin S, Barreau F, Berrebi D, Dussaillant M, Bonacorsi S, Chareyre F, Niwa-Kawakita M, Alberti C, Sterkers G, Villard C, Lesuffleur T, Peuchmaur M, Karin M, Eckmann L, Giovannini M, Ollendorff V, Wolf-Watz H, Hugot JP. Meinzer U, et al. Among authors: niwa kawakita m. PLoS One. 2008 Jul 23;3(7):e2769. doi: 10.1371/journal.pone.0002769. PLoS One. 2008. PMID: 18648508 Free PMC article.
24 results